当前位置:首页 / 急性心肌梗死患者血清淀粉样蛋白A水平与心肌缺血程度、心功能及中期预后的关联研究
| 更新时间:2026-11-20
|
急性心肌梗死患者血清淀粉样蛋白A水平与心肌缺血程度、心功能及中期预后的关联研究
Association of serum amyloid A level with myocardial ischemia severity, cardiac function, and medium-term prognosis in patients with acute myocardial infarction

内科 页码:558-564

作者机构:1 河南省职工医院心血管内二科,河南省郑州市 450002;2 郑州大学第一附属医院心血管内科重症监护病区,河南省郑州市 450052;3 河南省职工医院心血管内科,河南省郑州市 450002

DOI:10.16121/j.cnki.cn45-1347/r.2026.05.08

  • 中文简介
  • 英文简介
  • 参考文献

目的 探讨血清淀粉样蛋白A(SAA)水平与急性心肌梗死(AMI)患者心肌缺血程度、心功能及中期预后的关系。方法 纳入2021年1月至2024年5月于河南省职工医院确诊的AMI患者102例,以入院24 h内SAA≥100 mg/L为截断值分为高SAA组(34例)和低SAA组(68例)。收集基线临床特征、心肌缺血程度指标[ST段抬高幅度、心肌梗死溶栓(TIMI)血流分级]、心功能指标[左心室射血分数(LVEF)、N末端B型利钠肽原(NT-proBNP)]及SAA水平。随访自入院开始,平均(14.75±2.60)个月,主要终点为主要不良心血管事件(MACE)。采用Spearman秩相关分析SAA与各指标的相关性,分别以心肌缺血程度及心功能指标为因变量建立多因素回归模型,采用Cox比例风险模型评估SAA对MACE的预测价值,并进行亚组分析及交互作用检验。结果 (1)两组患者在人口学特征、心血管危险因素及梗死类型方面差异均无统计学意义(均P>0.05),组间基线均衡可比;高SAA组心肌肌钙蛋白I(cTnI)、肌酸激酶同工酶、C反应蛋白(CRP)水平及全球急性冠状动脉事件注册(GRACE)评分均高于低SAA组(均P<0.05)。(2)高SAA组ST段抬高幅度更大、TIMI血流2~3级比例更低, LVEF更低、NT-proBNP水平更高(均P<0.05)。(3)Spearman相关分析显示,SAA水平与ST段抬高幅度呈正相关(rₛ=0.328,P<0.001),与TIMI血流分级呈负相关(rₛ=-0.256,P=0.001),与LVEF呈负相关(rₛ=-0.287,P=0.003),与NT-proBNP呈正相关(rₛ=0.412,P<0.001)。(4)多因素回归分析显示,在统一校正性别、年龄、体重指数、高血压、糖尿病、cTnI及CRP后,SAA高水平是TIMI血流不良的独立影响因素(OR=0.862,95%CI:0.759~0.979,P=0.022),且与ST段抬高幅度独立正相关、与LVEF独立负相关、与NT-proBNP独立正相关(均P<0.05)。(5)随访期间共25例(24.51%)发生MACE;在核心混杂因素基础上额外校正GRACE评分、lnNT-proBNP及TIMI血流分级后,多因素Cox回归分析显示SAA高水平仍是MACE的独立预测因子(HR=1.820,95%CI:1.210~2.740,P=0.004);亚组分析显示梗死类型与SAA存在显著交互作用(P=0.045),年龄交互作用无统计学意义(P=0.123)。结论 SAA高水平与AMI患者更重的心肌缺血损伤、更差的心功能及更高的中期MACE风险独立相关,对疾病严重度评估和预后预测具有潜在临床价值。

Objective To investigate the association of serum amyloid A (SAA) level with myocardial ischemia severity, cardiac function, and medium-term prognosis in patients with acute myocardial infarction (AMI). Methods This prospective cohort study enrolled 102 patients diagnosed with AMI at Henan Provincial Staff Hospital between January 2021 and May 2024. Patients were stratified by SAA level within 24 hours of admission using a cutoff of 100 mg/L, yielding a high-SAA group (n=34) and a low-SAA group (n=68). Baseline clinical characteristics; indices of myocardial ischemic severity, including ST-segment elevation amplitude and Thrombolysis in Myocardial Infarction (TIMI) flow grade; cardiac function parameters, including left ventricular ejection fraction (LVEF) and N-terminal pro-B-type natriuretic peptide (NT-proBNP); and SAA levels were collected. Patients were followed from admission, with a mean follow-up of 14.75±2.60 months. The primary endpoint was major adverse cardiovascular events (MACE). Spearman rank correlation was used to assess correlations between SAA and each index. Multivariable regression models were constructed with myocardial ischemic severity and cardiac function parameters as dependent variables, respectively. Cox proportional hazards models were used to evaluate the predictive value of SAA for MACE, and subgroup analyses with interaction tests were performed. Results (1) No significant between-group differences were observed in demographic characteristics, cardiovascular risk factors, or MI type (all P>0.05), indicating comparable baseline characteristics. The high-SAA group had higher levels of cardiac troponin I (cTnI), creatine kinase-MB isoenzyme, C-reactive protein (CRP), and global registry of acute coronary events (GRACE) scores than the low-SAA group (all P<0.05). (2) The high-SAA group showed greater ST-segment elevation amplitude, a lower proportion of TIMI flow grade 2-3, lower LVEF, and higher NT-proBNP levels (all P<0.05). (3) Spearman correlation analysis revealed that SAA level was positively correlated with ST-segment elevation amplitude (rₛ=0.328, P<0.001) and NT-proBNP (rs=0.412, P<0.001), and negatively correlated with TIMI flow grade (rₛ=−0.256, P=0.001) and LVEF (rₛ=−0.287, P=0.003). (4) Multivariable regression analysis showed that after uniform adjustment for sex, age, body mass index (BMI), hypertension, diabetes, cTnI, and CRP, high SAA level was an independent factor for impaired TIMI flow (OR=0.862, 95%CI: 0.759-0.979, P=0.022), and was independently positively associated with ST-segment elevation amplitude and NT-proBNP, and independently negatively associated with LVEF (all P<0.05). (5) During follow-up, MACE occurred in 25 patients (24.51%). After additional adjustment for GRACE score, lnNT-proBNP, and TIMI flow grade on the basis of core confounders, multivariable Cox regression analysis demonstrated that high SAA level was an independent predictor of MACE (HR=1.820, 95%CI: 1.210-2.740, P=0.004). Subgroup analysis revealed a significant interaction between MI type (STEMI vs. NSTEMI) and SAA (P=0.045), whereas no significant interaction was observed for age (P=0.123). Conclusion Elevated SAA level is independently associated with more severe myocardial ischemia, worse cardiac function, and higher medium-term MACE risk in patients with AMI, suggesting its potential clinical value in disease severity assessment and prognostic prediction.

    无

6

浏览量

0

下载量

0

CSCD

工具集